Avinish Reddy, a physician at Elevated Medical, doesnt use NAD with his patients
A 2023 randomized crossover trial (the APRIL study) by Santangelo et al
Abstract Ferroptosis suppressor protein 1 (FSP1, also known as AIMF2, AMID or PRG3) is a recently identified glutathione-independent ferroptosis suppressor 1,2,3 , but its underlying structural mechanism remains unknown
Mounjaro received MHRA authorisation for type 2 diabetes in 2023 and is dispensed on NHS and private prescription
It's worth noting that in all of these trials, Foundayo was used in combination with lifestyle changes
The HGF mimics may be used to attenuate malignant and metastatic transformations